Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Haites

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|August 25, 1999
Haemochromatosis mutations in North-East ScotlandZ Miedzybrodzka, S Loughlin, D Baty, et al.
Clinical Genetics|September 17, 2003
To tell or not to tell: barriers and facilitators in family communication about genetic riskK Forrest, S A Simpson, B J Wilson, et al.
The Journal of Biological Chemistry|May 31, 2001
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotypeG S Stewart, J I Last, T Stankovic, et al.
Lancet (London, England)|May 9, 2006
Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort studyP Haggarty, H McCallum, H McBain, et al.
American Journal of Human Genetics|April 1, 1993
Linkage studies with 17q and 18q markers in a breast/ovarian cancer familyB J Milner, L A Allan, K F Kelly, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1992
The multidisciplinary management of a family with epithelial ovarian cancerD J Cruickshank, N Haites, S Anderson, et al.
British Journal of Cancer|July 13, 2006
Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trialsN Torrance, J Mollison, S Wordsworth, et al.
American Journal of Human Genetics|January 1, 1997
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evidentC Wicking, S Shanley, I Smyth, et al.
Disease Markers|December 14, 1999
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast CancerJ Chang-Claude, H Becher, M Caligo, et al.
Disease Markers|December 14, 1999
Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration ProjectM Steel, E Smyth, H Vasen, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|August 25, 1999
Haemochromatosis mutations in North-East ScotlandZ Miedzybrodzka, S Loughlin, D Baty, et al.
Clinical Genetics|September 17, 2003
To tell or not to tell: barriers and facilitators in family communication about genetic riskK Forrest, S A Simpson, B J Wilson, et al.
The Journal of Biological Chemistry|May 31, 2001
Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotypeG S Stewart, J I Last, T Stankovic, et al.
Lancet (London, England)|May 9, 2006
Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort studyP Haggarty, H McCallum, H McBain, et al.
American Journal of Human Genetics|April 1, 1993
Linkage studies with 17q and 18q markers in a breast/ovarian cancer familyB J Milner, L A Allan, K F Kelly, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1992
The multidisciplinary management of a family with epithelial ovarian cancerD J Cruickshank, N Haites, S Anderson, et al.
British Journal of Cancer|July 13, 2006
Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trialsN Torrance, J Mollison, S Wordsworth, et al.
American Journal of Human Genetics|January 1, 1997
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evidentC Wicking, S Shanley, I Smyth, et al.
Disease Markers|December 14, 1999
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast CancerJ Chang-Claude, H Becher, M Caligo, et al.
Disease Markers|December 14, 1999
Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration ProjectM Steel, E Smyth, H Vasen, et al.
Pageof 4